Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Saarlouis

5 clinical trials in Saarlouis, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Saarlouis at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Saarlouis

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Levodopa
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Universitaet Des Saarlandes
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enasidenib Mesilate
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Saarlouis

What the registry says about research in the country

01 Hematologic Malignancies

Innovative research focusing on acute myeloid leukemia (AML) and related conditions, evaluating novel therapeutic approaches for newly diagnosed patients.

  • AML with genetic variations
  • Myelodysplastic syndrome
  • IDH1/IDH2 mutations

Studies comparing intensive chemotherapy protocols and targeted therapies for improved patient outcomes.

02 Breast Cancer Research

Advanced studies in hormone receptor-positive breast cancer, investigating personalized treatment approaches and targeted therapies.

  • HER2-negative breast cancer
  • Endocrine therapy combinations
  • Ribociclib efficacy studies

Trials focusing on optimizing treatment strategies and monitoring disease progression patterns.

03 Lymphoma Studies

Comprehensive research on diffuse large B-cell lymphoma (DLBCL), exploring combination therapies for elderly patients.

  • B-cell lymphoma variants
  • Targeted immunotherapy approaches
  • Age-adapted treatment protocols

Investigating innovative treatment combinations to enhance survival outcomes in various lymphoma subtypes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.